Cytek Biosciences, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK, INC. | 05/02/2025 | 18.07 M | $72.46 M | -2.24% | 14.08% |
VANGUARD GROUP INC | 05/09/2025 | 9.62 M | $38.58 M | -17.88% | 7.50% |
BROWN CAPITAL MANAGEMENT LLC | 05/15/2025 | 7.46 M | $29.93 M | -9.49% | 5.82% |
HHLR ADVISORS, LTD. | 05/15/2025 | 6.66 M | $26.69 M | 0.00% | 5.19% |
STATE STREET CORP | 05/15/2025 | 4.38 M | $17.57 M | -2.84% | 3.41% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 2.85 M | $11.44 M | 55.91% | 2.22% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 2.69 M | $10.78 M | 1.80% | 2.09% |
NEW YORK STATE COMMON RETIREMENT FUND | 05/01/2025 | 2.09 M | $8.37 M | 0.00% | 1.63% |
TOPLINE CAPITAL MANAGEMENT, LLC | 05/14/2025 | 1.47 M | $5.90 M | 521.64% | 1.15% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 1.16 M | $4.64 M | -13.69% | 0.90% |
NORTHERN TRUST CORP | 05/13/2025 | 1.15 M | $4.62 M | -3.09% | 0.90% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 1.10 M | $4.43 M | 3.94% | 0.86% |
CENTERBOOK PARTNERS LP | 05/09/2025 | 845.41 K | $3.39 M | 100.00% | 0.66% |
MORGAN STANLEY | 05/15/2025 | 745.48 K | $2.99 M | -31.57% | 0.58% |
FMR LLC | 05/12/2025 | 717.16 K | $2.88 M | 4.97% | 0.56% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2025 | 708.48 K | $2.84 M | 100.00% | 0.55% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 692.40 K | $2.78 M | -5.24% | 0.54% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 687.60 K | $2.76 M | 48.64% | 0.54% |
JPMORGAN CHASE & CO | 05/12/2025 | 671.31 K | $2.69 M | -29.16% | 0.52% |
AQR CAPITAL MANAGEMENT LLC | 05/15/2025 | 653.28 K | $2.62 M | 394.38% | 0.51% |
UBS GROUP AG | 05/13/2025 | 611.53 K | $2.45 M | -8.14% | 0.48% |
CITADEL ADVISORS LLC | 05/15/2025 | 602.52 K | $2.42 M | 199.55% | 0.47% |
ROYCE & ASSOCIATES LP | 05/06/2025 | 565.82 K | $2.27 M | 20.18% | 0.44% |
TREXQUANT INVESTMENT LP | 05/14/2025 | 549.00 K | $2.20 M | 126.30% | 0.43% |
PRINCIPAL FINANCIAL GROUP INC | 04/28/2025 | 520.74 K | $2.09 M | 2.73% | 0.41% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 495.44 K | $1.99 M | -38.37% | 0.39% |
ALGERT GLOBAL LLC | 05/13/2025 | 411.43 K | $1.65 M | 17.24% | 0.32% |
PANAGORA ASSET MANAGEMENT INC | 05/15/2025 | 408.93 K | $1.64 M | 221.99% | 0.32% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 05/12/2025 | 359.58 K | $1.44 M | -40.24% | 0.28% |
JANE STREET GROUP, LLC | 05/19/2025 | 344.17 K | $1.38 M | 412.18% | 0.27% |
INVESCO LTD. | 05/12/2025 | 336.95 K | $1.35 M | 3.02% | 0.26% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 332.12 K | $1.33 M | -3.72% | 0.26% |
ACUITAS INVESTMENTS, LLC | 04/28/2025 | 331.22 K | $1.33 M | 100.00% | 0.26% |
PUBLIC SECTOR PENSION INVESTMENT BOARD | 05/12/2025 | 330.91 K | $1.33 M | 27.30% | 0.26% |
STATE OF WISCONSIN INVESTMENT BOARD | 05/15/2025 | 311.33 K | $1.25 M | 19.63% | 0.24% |
05/12/2025 | 304.99 K | $1.22 M | 100.00% | 0.24% | |
LEGAL & GENERAL GROUP PLC | 05/15/2025 | 296.83 K | $1.19 M | -5.18% | 0.23% |
RHUMBLINE ADVISERS | 05/29/2025 | 296.28 K | $1.19 M | 0.59% | 0.23% |
GLOBEFLEX CAPITAL L P | 05/12/2025 | 290.51 K | $1.16 M | 244.07% | 0.23% |
AMERIPRISE FINANCIAL INC | 05/14/2025 | 277.35 K | $1.11 M | 11.22% | 0.22% |
AMERICAN CENTURY COMPANIES INC | 05/13/2025 | 232.18 K | $931.02 K | 13.40% | 0.18% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 215.29 K | $863.31 K | 278.40% | 0.17% |
SWISS NATIONAL BANK | 05/12/2025 | 212.10 K | $850.52 K | -3.06% | 0.17% |
UBS ASSET MANAGEMENT AMERICAS INC | 05/19/2025 | 191.62 K | $768.41 K | -2.76% | 0.15% |
XTX TOPCO LTD | 05/08/2025 | 170.28 K | $682.82 K | 714.50% | 0.13% |
HRT FINANCIAL LP | 05/15/2025 | 165.31 K | $662.00 K | 100.00% | 0.13% |
CITIGROUP INC | 05/12/2025 | 156.14 K | $626.14 K | -2.53% | 0.12% |
BARCLAYS PLC | 05/15/2025 | 152.86 K | $613.00 K | -29.04% | 0.12% |
ALLIANCEBERNSTEIN L.P. | 05/15/2025 | 151.85 K | $608.91 K | 0.00% | 0.12% |
PDT PARTNERS, LLC | 05/15/2025 | 134.07 K | $537.60 K | 100.00% | 0.10% |
Cytek Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 177 institutional investors and hedge funds held shares of Cytek Biosciences, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 18.07 M
VANGUARD GROUP INC: 9.62 M
BROWN CAPITAL MANAGEMENT LLC: 7.46 M
HHLR ADVISORS, LTD.: 6.66 M
STATE STREET CORP: 4.38 M
DIMENSIONAL FUND ADVISORS LP: 2.85 M
60.38% of Cytek Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 94.54 M shares in the last 24 months. This purchase volume represents approximately $325.22 M in transactions.